| Cash Flow | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|---|
| Share-based compensation expense | 122,020 | 98,836 | 70,384 | 113,410 |
| Provision for credit losses | 45,514 | 12,355 | 3,871 | 30,216 |
| Net income | 1,900,885 | 1,211,136 | 493,719 | 1,511,807 |
| Other, net | 29,954 | -9,814 | -7,047 | -15,717 |
| Lifo credit | -19,913 | 32,145 | -7,324 | -64,441 |
| Prepaid expenses and other assets | -237,814 | -94,273 | -70,310 | -126,998 |
| Accrued expenses | -316,650 | -489,470 | -338,130 | -87,271 |
| Inventories | 949,881 | -34,252 | 1,655,165 | 835,633 |
| Income taxes receivable | - | - | - | -32,475 |
| Accounts receivable | 977,608 | 218,043 | 974,256 | 3,085,563 |
| Accounts payable | -61,892 | -669,479 | -654,165 | 4,112,542 |
| Gain on divestiture of equity investment | 12,838 | - | - | - |
| Loss on divestiture of businesses | -35,539 | -35,539 | -35,539 | - |
| Depreciation, including amounts charged to cost of goods sold | 367,582 | 237,226 | 113,629 | 336,955 |
| Provision (benefit) for deferred income taxes | 4,475 | 21,133 | -5,077 | -106,076 |
| Adjustments to rca equity units (note 2) | 74,920 | 37,460 | - | - |
| Amortization, including amounts charged to interest expense | 436,836 | 308,219 | 167,843 | 502,136 |
| Turkey highly inflationary impact | 42,859 | 26,060 | 7,666 | 44,664 |
| Income taxes payable and other liabilities | -127,446 | -145,700 | -51,193 | -97,896 |
| Long-term accrued litigation liability | 0 | 0 | 0 | -90,486 |
| (gain) loss on remeasurement of equity investment | 30,559 | 3,300 | 3,480 | -24,752 |
| Net cash provided by operating activities | 741,703 | 632,456 | -2,718,782 | 2,484,306 |
| Capital expenditures | 418,169 | 234,953 | 105,893 | 304,849 |
| Non-customer note receivable | 34,814 | 34,814 | 34,814 | 50,000 |
| Cost of equity investments | 193,792 | 192,576 | 182,014 | 14,981 |
| Cost of acquired companies, net of cash acquired | 4,004,220 | 3,947,761 | 9,015 | 24,487 |
| Other, net | 4,358 | 10,558 | 11,303 | -18,106 |
| Net cash used in investing activities | -4,655,353 | -4,420,662 | -343,039 | -376,211 |
| Senior notes and loan repayments | 763,412 | 548,565 | 44,950 | 659,255 |
| Repayments under revolving and securitization credit facilities | 86,120,601 | 42,948,335 | 13,427,095 | 56,744,334 |
| Exercises of stock options | 22,613 | 15,778 | 8,108 | 31,560 |
| Other, net | -24,908 | -18,762 | -16,876 | -11,641 |
| Borrowings under revolving and securitization credit facilities | 86,153,436 | 43,631,727 | 15,454,257 | 56,683,347 |
| Senior notes and loan borrowings | 4,508,482 | 3,320,674 | 1,806,028 | 688,321 |
| Employee tax withholdings related to restricted share vesting | 77,674 | 77,558 | 73,963 | 60,121 |
| Cash dividends on common stock | 329,569 | 222,076 | 110,888 | 315,223 |
| Purchases of common stock | 435,471 | 435,471 | 385,471 | 986,388 |
| Net cash provided by (used in) financing activities | 2,932,896 | 2,717,412 | 3,209,150 | -1,373,734 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | -41,800 | -48,520 | -50,235 | -10,854 |
| (decrease) increase in cash, cash equivalents, and restricted cash | -1,022,554 | -1,119,314 | 97,094 | 723,507 |
Cencora, Inc. (COR)
Cencora, Inc. (COR)